Pressure BioSciences, Inc.
PBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29,314 | -$16,077 | -$20,153 | -$16,006 |
| Dep. & Amort. | $112 | $120 | $110 | $127 |
| Deferred Tax | $0 | $0 | -$277 | -$500 |
| Stock-Based Comp. | $6,682 | $215 | $255 | $489 |
| Change in WC | $309 | $3,023 | $202 | $4,028 |
| Other Non-Cash | $19,025 | $8,241 | $14,995 | $6,978 |
| Operating Cash Flow | -$3,186 | -$4,478 | -$4,869 | -$4,883 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$21 | -$123 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$795 |
| Investing Cash Flow | -$7 | -$21 | -$123 | -$797 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,715 | $4,328 | $4,076 | $5,519 |
| Stock Issued | $231 | $25 | $7,265,954 | $150 |
| Stock Repurch. | $0 | $0 | -$7,081,680 | $0 |
| Dividends Paid | $0 | -$386,300 | -$184,274 | -$299,709 |
| Other Fin. Act. | $325 | $386,317 | $185,304 | $299,859 |
| Financing Cash Flow | $3,271 | $4,370 | $5,105 | $5,669 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $77 | -$128 | $114 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4 | $132 | $19 | $30 |
| End Cash | $81 | $4 | $132 | $19 |
| Free Cash Flow | -$3,194 | -$4,499 | -$4,992 | -$4,885 |